Navigation Links
Recombinant DNA technology may enable oral, rather than injectable, delivery of protein drugs

s insulin, growth hormone, and erythropoietin, a medication to increase red blood cell counts."

Recombinant DNA technology has and will enable the pharmaceutical industry to produce safer, more pure and more effective versions of therapeutic proteins, Shen adds.

"Since recombinant therapeutics utilize human proteins, they do not induce an unwanted immune response like products created from non-human sources often do."

On behalf of Shen and his collaborators, USC holds the patent to the new recombinant fusion protein technology. The research was supported by grants from the National Institutes of Health.


'"/>

Source:Eurekalert


Page: 1 2 3

Related biology news :

1. Live Recombinant Adenovirus Vaccine Technique Explored
2. Novel technology detects human DNA mutations
3. Novel antiviral technology inhibits RSV infection in mice
4. The BIOS Initiative - open source biotechnology is born
5. Revolutionary nanotechnology illuminates brain cells at work
6. Study: homemade gene expression technology unreliable
7. First technology to remove prions that cause vCJD from blood launched
8. Integration of Agilents MS technology, Proteome Systems software to help scientists in proteomics research
9. Agilent Technologies new genome analysis technology set to accelerate Australia fight against mesothelioma
10. First production of human monoclonal antibodies in chicken eggs published in Nature Biotechnology
11. Vietnam war technology could aid elephant conservation
Post Your Comments:
(Date:11/20/2008)...n German . , Halle/Saale. For the first ti...iew of which alien species are present in Europe, ... and society. More than 11,000 alien species have ...ve Species Inventory for Europe), a unique three y...cientists, funded by the European Union that provi...
(Date:11/20/2008)...ting an ageing population, and turning research in...20 million ($30.4 million) investment announced to...rch Council (EPSRC), Technology Strategy Board (TS...esearch Council (BBSRC). , This new investment w...ass scientific breakthroughs have already been ach...
(Date:11/19/2008)...irth, mouse ovaries are essentially a bag full of ...les are forming. This key time in ovarian developm...icles and instigates evelopment of a cohort of fol...ocyte demise, yet oocytes are also essential for f...icular formation and oocyte survival have been dis...
(Date:11/19/2008)...at range northward because of climate change may b...mies than native plants. , So concludes a team o...eticist. The team,s findings, reported in today,s ...lants could become invasive if they spread to plac...is paper is the first to suggest that the mechanis...
Breaking Biology News(10 mins):11,000 alien species invade Europe 2£20 million to fight virtual crime and treat our aging population 2£20 million to fight virtual crime and treat our aging population 3December 2008 highlights from Biology of Reproduction 2Climate change opens new avenue for spread of invasive plants 2LaVoie Group Adds Cancer Therapeutics Company Neotropix 28R 29 to Its Life Science Agency Roster 26846 1LaVoie Group Adds Cancer Therapeutics Company Neotropix 28R 29 to Its Life Science Agency Roster 26846 2Combined Insurance Encourages Women to Assess Insurance Plans and Protection During Breast Cancer Awareness Month 26843 1Combined Insurance Encourages Women to Assess Insurance Plans and Protection During Breast Cancer Awareness Month 26843 2Combined Insurance Encourages Women to Assess Insurance Plans and Protection During Breast Cancer Awareness Month 26843 3Combined Insurance Encourages Women to Assess Insurance Plans and Protection During Breast Cancer Awareness Month 26843 4SAFC Pharma Completes Large Scale API Manufacturing Expansion in Ireland 7953 1SAFC Pharma Completes Large Scale API Manufacturing Expansion in Ireland 7953 2SAFC Pharma Completes Large Scale API Manufacturing Expansion in Ireland 7953 3Entomological Society of America names 2008 award winners 5106 1Entomological Society of America names 2008 award winners 5106 2Entomological Society of America names 2008 award winners 5106 3Entomological Society of America names 2008 award winners 5106 4Entomological Society of America names 2008 award winners 5106 5Entomological Society of America names 2008 award winners 5106 6Entomological Society of America names 2008 award winners 5106 7Entomological Society of America names 2008 award winners 5106 8Entomological Society of America names 2008 award winners 5106 9Entomological Society of America names 2008 award winners 5106 10Entomological Society of America names 2008 award winners 5106 11Entomological Society of America names 2008 award winners 5106 12Entomological Society of America names 2008 award winners 5106 13
...e remains the most desired tool to combat the wors...s. Pierre Druilhe and colleagues (from the Institu... trial of a vaccine based on MSP3, a protein prese...ry encouraging results. , As the researchers rep...al PLoS Medicine, most of the 30 healthy volunteer...
...rsity study published this week in Nature shows fo... coherence among brain clock cells that regulate d...ies). The two key groups of neurons control mornin... even when the flies are plunged into darkness for... signal flows from the morning to the evening cell...
...CLA,s Jonsson Cancer have identified key character...em 51 times more likely to respond to a specific c...ignature is absent. , The discovery of the telltal...protein and the presence of a tumor suppressor pro...fy patients who are likely to respond to the drug ...
...ase Western Reserve University School of Medicine ...at the Food and Drug Administration (FDA) has appr... of using adult stem cells from bone marrow to tre...se. , The FDA has approved a Phase I study designe...volve injecting bone marrow stem cells at varying ...
Other Biology News:A resetting signal keeps circadian rhythm on track in Drosophila fruit flies 2UCLA discovery will aid in treatment of patients with a deadly brain cancer 2UCLA discovery will aid in treatment of patients with a deadly brain cancer 3Feds give researchers ok for safety test of adult stem cells in patients with heart disease 2
(Date:11/21/2008)...tCall/ -- BioMarin Pharmaceutical,Inc. (Nasdaq: ...Chief Medical,Officer will retire from the compan...o leave his position with the company to allow him...l endeavors related to rare diseases. Dr.,Kakkis...for the foreseeable,future. , "I am extrem...
(Date:11/21/2008)...tCall/ -- CorVel Corporation,(Nasdaq: CRVL ) an...der the new,Medicare legislation requiring expand...tors and employers. The Company currently provide...compensation and general liability,customers thro...offering to,include communications soon to be man...
(Date:11/21/2008)...ge Center is First Integrated Knowledge Center Out... Hyderabad, India (Vocus) November 21, 2008 -&ndas... today, 17 months after breaking ground last summe...k in the city’s Genome Valley, the center wi...c region in the areas of agricultural and industri...
(Date:11/21/2008)...RUCTURING ALTERNATIVES ONGOING , , VANCOUVE...maceuticals, Inc. (NASDAQ: ANPI , TSX: ANP), a g...company, today announced that the Company had been...enture Partners (New Leaf) that they had elected t... 7, 2008. Angiotech had announced on September 22,...
Breaking Biology Technology:BioMarin Announces the Planned Retirement of Dr. Emil Kakkis, Chief Medical Officer 2BioMarin Announces the Planned Retirement of Dr. Emil Kakkis, Chief Medical Officer 3BioMarin Announces the Planned Retirement of Dr. Emil Kakkis, Chief Medical Officer 4CorVel Announces MSA Agent Services 2CorVel Announces MSA Agent Services 3DuPont Opens Research & Development Center in India 2DuPont Opens Research & Development Center in India 3Angiotech announces termination of note purchase agreement with Ares Management and New Leaf Venture Partners 2Angiotech announces termination of note purchase agreement with Ares Management and New Leaf Venture Partners 3Angiotech announces termination of note purchase agreement with Ares Management and New Leaf Venture Partners 4
..., , , , , Here are some tro... regarding misincorporation or low fidelity of PC... , , , , ... , , <a , ... , , , , ...
..., , for prevention of carry-over contam...its , Cat. No. 1 269 062 25 units, ,..., , , Uracil-DNA Glycosylase (UNG) (fro... from single- and double-stranded DNA that has be...he apyriminic sites formed by UNG are susceptible ...
..., Kit for PCR and PCR carry-over prevention Ca..., , , , , , Description ,...ll basic reagents to perform , a polymerase...NA , and appropriate primers. The kit con... Taq DNA Polymerase , PCR Nucle...
..., for amplification of long targets (up to 35 ...1 002 100 units , , , , , , ...nd containing Taq and Pwo DNA Polymerase and anoth...PLUS PCR System also includes , an optimiz... a human control DNA (template DNA plus beta-g...
Other Biology Technology:Trouble-shooting: Misincorporation or low fidelity 2Trouble-shooting: Misincorporation or low fidelity 3Uracil-DNA Glycosylase 2PCR Core KitPLUS 2Expand 20 kbPLUS PCR System 2
Rab 3 Immunogen: Synthetic peptide corresponding to the N-terminal region of Rab 3 protein. Storage: -20 C, Avoid Freeze/Thaw Cycles
Mouse monoclonal [2G1] to Vancomycin ( Abpromise for all tested applications).
Chicken polyclonal to LYZL6 ( Abpromise for all tested applications). Antigen: Synthetic peptide: DWLCL AFVE SKFNISKINE NADGSFDYGL FQINSHYWCN DYKSYSENLC HVDCQD , corresponding to amino acids 46-
Mouse monoclonal [DJR3] to DcR1 (Phycoerythrin) ( Abpromise for all tested applications). entrezGeneID: 8794 SwissProtID: O14798
Biology Products: